Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. | 66,900 | reported | 21 May 2026 | tx 9+148,211 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | PURCHASE | Amylyx Pharmaceuticals, Inc. | 3,800 | 13.51 USD | |
| 23 Dec 2025 | PURCHASE | Amylyx Pharmaceuticals, Inc. | 8,100 | 12.45 USD | first after silence |
| 05 Jun 2025 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 05 Sept 2024 | PURCHASE | Amylyx Pharmaceuticals, Inc. | 50,000 | 2.13 USD | |
| 06 Jun 2024 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 15 Dec 2023 | PURCHASE | Amylyx Pharmaceuticals, Inc. | 4,000 | 14.97 USD | |
| 08 Jun 2023 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 3,908 | 0.00 USD | deriv |
| 16 Mar 2023 | PURCHASE | Amylyx Pharmaceuticals, Inc. | 1,000 | 31.99 USD | |
| 16 Mar 2023 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 27,403 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 23 Dec 2025.